NRC Health
NRC
$18.62
-$0.31-1.64%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.73% | -4.64% | -3.38% | -2.81% | -4.99% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.73% | -4.64% | -3.38% | -2.81% | -4.99% |
| Cost of Revenue | 4.51% | -2.89% | -18.95% | -3.34% | -5.77% |
| Gross Profit | 3.24% | -5.75% | 8.24% | -2.48% | -4.49% |
| SG&A Expenses | 29.58% | -30.63% | 11.68% | 58.04% | -7.95% |
| Depreciation & Amortization | 40.66% | 41.49% | 41.98% | 15.14% | 6.57% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.15% | -11.91% | -3.48% | 24.06% | -6.02% |
| Operating Income | -35.21% | 15.43% | -3.03% | -82.09% | -1.87% |
| Income Before Tax | -43.30% | -63.17% | -14.02% | -93.02% | -5.75% |
| Income Tax Expenses | -40.24% | -36.46% | 33.77% | -68.03% | 5.50% |
| Earnings from Continuing Operations | -44.32% | -72.59% | -27.53% | -101.72% | -9.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -44.32% | -72.59% | -27.53% | -101.72% | -9.00% |
| EBIT | -35.21% | 15.43% | -3.03% | -82.09% | -1.87% |
| EBITDA | -23.67% | 18.92% | 4.27% | -67.91% | -0.68% |
| EPS Basic | -43.75% | -72.52% | -24.73% | -103.25% | -5.44% |
| Normalized Basic EPS | -40.22% | 16.92% | -7.80% | -92.66% | -2.10% |
| EPS Diluted | -44.00% | -74.40% | -24.94% | -103.87% | -6.16% |
| Normalized Diluted EPS | -40.55% | 16.89% | -7.71% | -92.64% | -1.68% |
| Average Basic Shares Outstanding | -5.11% | -6.71% | -6.71% | -5.08% | -3.75% |
| Average Diluted Shares Outstanding | -4.63% | -6.67% | -6.80% | -5.26% | -4.13% |
| Dividend Per Share | 33.33% | 33.33% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.35% | 2.49% | 0.34% | -56.57% | 0.05% |